Section Arrow
TLSI.NASDAQ
- TriSalus Life Sciences
Quotes are at least 15-min delayed:2026/11/20 17:46 EST
After Hours
Last
 2.31
-0.01 (-0.43%)
Bid
2.27
Ask
2.32
High 2.34 
Low 2.31 
Volume 790 
Regular Hours (Closed)
Last
 2.32
+0.145 (+6.67%)
Day High 
2.3699 
Prev. Close
2.175 
1-M High
4.075 
Volume 
539.26K 
Bid
2.27
Ask
2.32
Day Low
2.19 
Open
2.19 
1-M Low
2.165 
Market Cap 
134.20M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.58 
20-SMA 3.14 
50-SMA 3.85 
52-W High 7.95 
52-W Low 2.165 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.41/-0.48
Enterprise Value
168.47M
Balance Sheet
Book Value Per Share
0.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.5 +0.52 +1.24%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.66 +0.03 +1.84%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.5 -0.44 -0.44%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.92 +0.011 +1.21%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 104.33 +1.33 +1.29%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9)agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.